TRANSESOPHAGEAL DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN THE EVALUATION OF CORONARY-ARTERY DISEASE

被引：25

作者：

FROHWEIN, S ^{[1
]}

KLEIN, JL ^{[1
]}

LANE, A ^{[1
]}

TAYLOR, WR ^{[1
]}

机构：

[1] EMORY UNIV, SCH MED, DIV CARDIOL, ATLANTA, GA 30322 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1995年 / 25卷 / 04期

关键词：

D O I：

10.1016/0735-1097(94)00464-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives. The goal of this study was to determine the feasibility safety, sensitivity and specificity of transesophageal debutamine stress echocardiography for the detection of coronary artery disease. Background. Dobutamine stress echocardiography has been shown to be an extremely sensitive and specific noninvasive technique for the detection of myocardial ischemia. However, inadequate transthoracic images preclude the use of dobutamine stress echocardiography in a small but significant group of patients. Transesophageal echocardiography provides better resolution than that obtained with routine transthoracic imaging. Methods. Patients scheduled for routine cardiac catheterization undenvent transesophageal dobutamine stress echocardiography. All patients undenvent coronary arteriography within 48 h of the study, and lesion severity,vas determined by quantitative coronary angiography, Significant coronary obstruction was defined as stenosis > 50%. Results. Fifty-one male patients were enrolled in the study; six were excluded for technical reasons, There were no adverse outcomes or complications. Of 27 patients with significant coronary artery disease, 22 had positive study results (sensitivity 82%). Of 13 patients without significant obstructive coronary disease, 1 had a false positive study result (specificity 93%). In patients,vith a minimal lumen diameter < 1.25 mm, sensitivity was > 80%, and in patients with a minimal lumen diameter > 1.5 mm, sensitivity was < 70%, suggesting that lesions with a minimal lumen diameter < 1.25 mm are more likely to be physiologically significant. Conclusions. Transesophageal dobutamine stress echocardiography is a feasible, safe and accurate technique for the detection of myocardial ischemia. There are inherent limitations to this technique in that transesophageal echocardiography must be performed. Transesophageal dobutamine stress echocardiography may allow extension of dobutamine stress testing to patients with inadequate transthoracic echocardiographic imaging and may provide an opportunity for further research applications.

引用

页码：823 / 829

页数：7

共 38 条

[11]

Previtali, Fetiveau, Poli, Et al., Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease, Am J Cardiol, 72, pp. 865-870, (1993)

[12]

Smart, Sawada, Ryan, Et al., Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction, Circulation, 88, pp. 405-415, (1993)

[13]

Berthe, Pierard, Hiernaux, Et al., Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion, Am J Cardiol, 58, pp. 1167-1172, (1986)

[14]

Mannering, Cripps, Leech, Et al., Dobutamine stress test as an alternative to exercise testing after acute myocardial infarction, Heart, 59, pp. 521-526, (1986)

[15]

Poldermans, Fioretti, Forster, Et al., Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery, Circulation, 87, pp. 1506-1512, (1993)

[16]

Davila-Roman, Waggoner, Sicard, Geltman, Schechtman, Perez, Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease, J Am Coll Cardiol, 21, pp. 957-963, (1993)

[17]

Lane, Sawada, Segar, Et al., Dobutamine stress echocardiography for assessment of cardiac risk before non cardiac surgery, Am J Cardiol, 68, pp. 976-977, (1991)

[18]

Cigarroa, deFilippi, Brickner, Alvarez, Wait, Grayburn, Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization, Circulation, 88, pp. 430-436, (1993)

[19]

Barilla, Gheorghiade, Alam, Khaja, Goldstein, Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude in response to coronary revascularization, Am Heart J, 122, pp. 1522-1531, (1991)

[20]

Akosah, Porter, Simon, Funai, Minisi, Mohanty, Ischemia-induced regional wall motion abnormality is improved after coronary angioplasty: demonstration by dobutamine stress echocardiography, J Am Coll Cardiol, 21, pp. 584-589, (1993)

← 1 2 3 4 →